Announced Sat, 23 May · 15:56 IST

We wish to inform you that the Board of directors had approved the Re-appointment of Cost & Internal auditors of the company.

Management Changes View source PDF

KOVAI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹5375.00
prior close
₹5421.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.8-0.8-0.9-1.3+0.5-0.2+0.8-0.6-0.9+7.7+11.4+7.7
Up moveDown movePending
AI summary

Kovai Medical Center & Hospital reported strong audited FY2026 results. Total revenue grew 15.8% to Rs.1,61,388 Lakhs (vs Rs.1,39,322 Lakhs in FY25), with Profit Before Tax rising 17.3% to Rs.32,569 Lakhs and Net Profit at Rs.24,446 Lakhs, up 17% YoY. Basic EPS stood at Rs.223.41. The Board recommended a 150% final dividend (Rs.15 per share), subject to shareholder approval at the 40th AGM on 26th August 2026 (record date 19th August). Cost Auditor Mr. V. Sakthivel (RKMS & Associates) and Internal Auditor Mr. G. Jawaharlal were re-appointed for FY2026-27. The statutory auditors issued an unmodified opinion on the financials.

Likely market impact

Solid operational performance with double-digit revenue and profit growth. The 150% dividend signals confidence, and the re-appointment of auditors indicates stability. No governance red flags identified in this filing.